Abbott, Pfizer in pact for lung cancer screening
Friday, August 28, 2009 - 23:45
in Health & Medicine
CHICAGO (Reuters) - An Abbott Laboratories Inc unit that makes genetic tests will work with Pfizer Inc to develop a test to screen non-small cell lung cancer (NSCLC) tumors to determine which patients are good candidates for a novel cancer therapy being developed by Pfizer.